Full-Time
Operations Technician
Operations Team
Posted on 8/21/2025
Biote
201-500 employees
Clinically validated hormone optimization and treatment
No salary listed
Birmingham, AL, USA
In Person
 Operations & Logistics (2) |
|---|
| , |
- High School Diploma/GED.
- Minimum of 2 years’ related experience in pharmacy or CGMP expertise desired.
- Works well under pressure and demonstrates the ability to prioritize workloads.
- Excellent problem solving and analytical skills.
- Judgement is required in resolving complex problems based on experience.
- Ability to work in ISO 8 Class cleanroom environment following appropriate gowning procedures and wearing Powered Air Purifying Respirators (PAPRs) as required.
- Light to moderate lifting of up to 50lbs.
- Standing or sitting for long periods of time.
- Follows all Company policies and applies appropriate operating and maintenance procedures.
- Maintains general knowledge of site/location/equipment and permitting.
- Perform and document production using Current Good Manufacturing Practices (CGMP) and Good Documentation Practices (GDPs).
- Completes assigned reports, logs and maintains accurate records of process operations and performance of preventative maintenance on equipment as needed.
- Performs work during an assigned shift in a safe, continuous and efficient manner while maintaining workplace standards within federal, state and local guidelines.
- Work collaboratively with other cross functional work teams.
- Perform other related duties, as assigned.
- None
Biote focuses on hormone optimization using clinically validated medical approaches to identify and treat imbalances in hormone production. It uses lab testing and medical assessment to pinpoint hormone deficiencies or excesses, then prescribes personalized treatment plans—often including bio-identical hormone therapy and related regimens—under medical supervision to restore balanced hormone levels. Biote differentiates itself through its emphasis on translating extensive scientific insight (80+ years of research) into validated protocols and continuing medical oversight, rather than generic supplements. The company’s goal is to help patients achieve balanced hormone levels and improve health outcomes by delivering scientifically grounded, physician-guided hormone optimization.
Company Size
201-500
Company Stage
IPO
Headquarters
Irving, Texas
Founded
2012
Simplify's Take
What believers are saying
- Acquired Asteria Health for $8.5M, expanding compounded hormone manufacturing.
- Appointed Robert Peterson CFO on January 8, 2024, strengthening finance leadership.
- Hired John Denne as men's health GM, driving expansion into male hormone therapy.
What critics are saying
- FDA enforcement targets Biote's unsubstantiated compounding claims within 12-24 months.
- UnitedHealth, Anthem, Aetna deny BHRT reimbursement, slashing provider revenues in 6-18 months.
- Texas, California, Florida boards suspend Asteria licenses, disrupting supply chain in 12-24 months.
What makes Biote unique
- Biote Method platform provides education, training, certification, software, and marketing to 7,100 providers.
- Sells sterile pellet insertion kits and branded dietary supplements for hormone optimization.
- Performed over 4 million pellet insertions, proving expertise in precision preventive medicine.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Paid Time Off
Company News
Hemingway Medical Spa Inc. partnered with Biote because they share its commitment to improving the quality of patients lives through a more natural and less pharmacologic approach.
Hampton Roads Orthopaedics and Sports Medicine has chosen Biote as its partner for hormone replacement therapy due to their proven track record and commitment to excellence.
Irving-based Biote Corp. announced that it will acquire Asteria Health, a privately held manufacturer of compounded bioidentical hormones, in a deal valued at $8.5 million.
biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hor
biote Corp., a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, announced that Robert Peterson has been named Chief Financial Officer, effective January 8, 2024.